Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 2000;7(6):293–299. doi: 10.1155/MBD.2000.293

Interaction of Cis- and Trans-RuCl 2(DMSO)4 With Human Serum Albumin

Lilianna Trynda-Lemiesz 1,, Henryk Kozlowski 1, Nikolas Katsaros 2
PMCID: PMC2365239  PMID: 18475961

Abstract

The interaction between cis- and trans- RuCl2(DMSO)4 and human serum albumin have been investigated through UV-Vis, circular dichroism, fluorescence spectroscopy and inductively couplet plasma atomic emission spectroscopy (ICP(AES)) method Albumin can specifically bind 1 mole of cis-isomer and 2 moles of the trans-isomer RuCl2(DMSO)4 complex. The interaction of RuCl2(DMSO)4 with HSA causes: a conformational change with the loss of helical stability of protein; the strong quenching of the Trp 214 fluorescence indicating that the conformational change of the hydrophobic binding pocked in subdomain IIA takes place; a local perturbation of the warfarin binding site and induce some conformational changes at neighbour domains, a changing of the binding abilities towards heme.

Full Text

The Full Text of this article is available as a PDF (922.1 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES